Stay updated on OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.

Latest updates to the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.3.4 replaces v3.3.3. No substantive content changes are visible on the page.SummaryDifference0.0%

- Check10 days agoChange DetectedAdded a Publications section with the OPERA-01 publication (Pistilli et al., Future Oncol, 2025) and a PubMed auto-fill note.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedMany new recruitment sites were added across the US, Argentina, Australia, and numerous European and Asian countries, expanding the geographic availability of study sites. At the same time, a large number of existing locations were removed.SummaryDifference4%

- Check53 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed.SummaryDifference0.1%

- Check60 days agoChange DetectedRemoved the general operations notice about government funding; this is a minor change that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check67 days agoChange DetectedUpdated the trial site location name from Tainan City to Tainan (Taiwan, 736) in the Locations section.SummaryDifference0.0%

Stay in the know with updates to OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the OP-1250 vs Standard in ER+/HER2- Advanced Breast Cancer Clinical Trial page.